Johnson David Michael bought ZNTL
June 16, 2026 · Form 4 insider transaction
Johnson David Michael bought 57,100 shares of Zentalis Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
57,100
Price
$0.00
Total value
N/A
InsiderJohnson David Michael
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 16, 2026
Filing dateJune 18, 2026
Shares owned after307,521
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 16, 2027 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.